Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).

Novartis Media Relations E-mail: media.relations@novartis.com Novartis Investor Relations Central investor relations line: +41 ...

Published in the Journal of the American Heart Association1, new research focused on age-adjusted mortality rates for a variety of heart disease subtypes among adults 25 years and ...

Analysis highlights the widespread underuse of statins and cholesterol-lowering therapies among eligible adults in the United ...

Aging brain adapts through pathways to process emotional ambiguity, offering new hope for emotional resilience and healthy ...

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.

More bed rest after a stroke may affect memory and brain health. Balanced rest and activity can help with better recovery.

A vegan or Mediterranean “acid-busting” diet can reduce body acid load, support fat loss, and improve metabolic health in ...

Heart attack deaths have dropped by nearly 90% since 1970, but deaths from other heart conditions like heart failure are ...

Half of clinical trials on adult ADHD lack thorough diagnostic assessments, undermining their reliability and treatment ...

Multimodal AI chatbots assist gastroenterologists in real time, combining image, text, and context for smarter, faster endoscopy-based decisions.

Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseases ...